Merck (MRK) Q3 Earnings Top, Sales Lag, Keytruda Stays Strong
October 27, 2017 at 16:00 PM EDT
Merck & Co., Inc. reported third-quarter 2017 adjusted earnings of $1.11 per share, which beat the Zacks Consensus Estimate of $1.03 by 7.8%. Earnings rose 3.7% year over year.
